Respiratory Mononuclear Phagocytes in Human Influenza A Virus Infection: Their Role in Immune Protection and As Targets of the Virus

Frontiers in Immunology

Volumn 9, Issue , 2018, Pages

  Vangeti, Sindhu ^a   Yu, Meng ^a   Smed Sörensen, Anna ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

dendritic cell; emerging; influenza; macrophage; monocyte; respiratory; virus

Indexed keywords

EID: 85066015474     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2018.01521     Document Type: Review

References (154)

1. Hirsch A. Handbook of Geographical and Historical Pathology. London: The New Sydenham Society (1883).
2. Potter CW. A history of influenza. J App Microbiol. (2001) 91:572–9.10.1046/j.1365-2672.2001.01492.x
3. Dunn JJ, Miller MB. Emerging respiratory viruses other than influenza. Clin Lab Med (2014) 34(2):409–30.10.1016/j.cll.2014.02.01124856535
4. Hui DS, Zumla A. Emerging respiratory tract viral infections. Curr Opin Pulm Med (2015) 21(3):284–92.10.1097/MCP.000000000000015325764021
5. Gao GF. From “A”IV to “Z”IKV: attacks from emerging and re-emerging pathogens. Cell (2018) 172(6):1157–9.10.1016/j.cell.2018.02.025
6. Bedford T, Suchard MA, Lemey P, Dudas G, Gregory V, Hay AJ, et al. Integrating influenza antigenic dynamics with molecular evolution. Elife (2014) 3:e01914.10.7554/eLife.0191424497547
7. Drake JW. Rates of spontaneous mutation among RNA viruses. Proc Natl Acad Sci U S A (1993) 90:4171–5.10.1073/pnas.90.9.41718387212
8. Drake JW, Holland JJ. Mutation rates among RNA viruses. Proc Natl Acad Sci U S A (1999) 96(24):13910–3.10.1073/pnas.96.24.1391010570172
9. Chen H, Deng Q, Ng SH, Lee RT, Maurer-Stroh S, Zhai W. Dynamic convergent evolution drives the passage adaptation across 48 years’ history of H3N2 influenza evolution. Mol Biol Evol (2016) 33(12):3133–43.10.1093/molbev/msw19027604224
10. WHO. The Top 10 Causes of Death – Fact Sheet No. 310 2014. Geneva: WHO (2017). Available from: http://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death (Accessed: March 14, 2018).
11. Russell CA, Kasson PM, Donis RO, Riley S, Dunbar J, Rambaut A, et al. Improving pandemic influenza risk assessment. Elife (2014) 3:e03883.10.7554/eLife.0388325321142
12. Petrova VN, Russell CA. The evolution of seasonal influenza viruses. Nat Rev Microbiol (2018) 16(1):47–60.10.1038/nrmicro.2017.11829081496
13. Wootton S, Aguilera EA, Wanger A, Jewell A, Patel K, Murphy JR, et al. Detection of NH1N1 influenza virus in nonrespiratory sites among children. Pediatr Infect Dis J (2014) 33(1):95–6.10.1097/INF.0b013e3182a09de724346599
14. Zhu L, Liu L, Zhang Y, Pu L, Liu J, Li X, et al. High level of neutrophil extracellular traps correlates with poor prognosis of severe influenza A infection. J Infect Dis (2018) 217(3):428–37.10.1093/infdis/jix47529325098
15. Wang K, Lai C, Li T, Wang C, Wang W, Ni B, et al. Basic fibroblast growth factor protects against influenza A virus-induced acute lung injury by recruiting neutrophils. J Mol Cell Biol (2017) 1–13.10.1093/jmcb/mjx04729121325
16. Buttignol M, Pires-Neto RC, Rossi ESRC, Albino MB, Dolhnikoff M, Mauad T. Airway and parenchyma immune cells in influenza A(H1N1)pdm09 viral and non-viral diffuse alveolar damage. Respir Res (2017) 18(1):147.10.1186/s12931-017-0630-x28774302
17. Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet (2018) 391(10127):1285–300.10.1016/S0140-6736(17)33293-229248255
18. Summers JA, Stanley J, Baker MG, Wilson N. Risk factors for death from pandemic influenza in 1918-1919: a case-control study. Influenza Other Respir Viruses (2014) 8(3):329–38.10.1111/irv.1222824490663
19. Gagnon A, Miller MS, Hallman SA, Bourbeau R, Herring DA, Earn DJ, et al. Age-specific mortality during the 1918 influenza pandemic: unravelling the mystery of high young adult mortality. PLoS One (2013) 8(8):e69586.10.1371/journal.pone.006958623940526
20. Ma J, Dushoff J, Earn DJ. Age-specific mortality risk from pandemic influenza. J Theor Biol (2011) 288:29–34.10.1016/j.jtbi.2011.08.00321856313
21. Viboud C, Simonsen L, Fuentes R, Flores J, Miller MA, Chowell G. Global mortality impact of the 1957-1959 influenza pandemic. J Infect Dis (2016) 213(5):738–45.10.1093/infdis/jiv53426908781
22. Taubenberger JK, Morens DM. The pathology of influenza virus infections. Annu Rev Pathol (2008) 3:499–522.10.1146/annurev.pathmechdis.3.121806.15431618039138
23. Taubenberger JK, Reid AH, Krafft AE, Bijwaard KE, Fanning TG. Initial genetic characterization of the 1918 “Spanish” influenza virus. Science (1997) 275:1793–6.10.1126/science.275.5307.1793
24. Connors TJ, Ravindranath TM, Bickham KL, Gordon CL, Zhang F, Levin B, et al. Airway CD8(+) T cells are associated with lung injury during infant viral respiratory tract infection. Am J Respir Cell Mol Biol (2016) 54(6):822–30.10.1165/rcmb.2015-0297OC26618559
25. Gerlach RL, Camp JV, Chu YK, Jonsson CB. Early host responses of seasonal and pandemic influenza A viruses in primary well-differentiated human lung epithelial cells. PLoS One (2013) 8(11):e78912.10.1371/journal.pone.007891224244384
26. Gerlach T, Hensen L, Matrosovich T, Bergmann J, Winkler M, Peteranderl C, et al. pH optimum of hemagglutinin-mediated membrane fusion determines sensitivity of influenza A viruses to the interferon-induced antiviral state and IFITMs. J Virol (2017) 91(11):1–16.10.1128/JVI.00246-1728356532
27. Kroetz DN, Allen RM, Schaller MA, Cavallaro C, Ito T, Kunkel SL. Type I interferon induced epigenetic regulation of macrophages suppresses innate and adaptive immunity in acute respiratory viral infection. PLoS Pathog (2015) 11(12):e1005338.10.1371/journal.ppat.100533826709698
28. Travanty E, Zhou B, Zhang H, Di YP, Alcorn JF, Wentworth DE, et al. Differential susceptibilities of human lung primary cells to H1N1 influenza viruses. J Virol (2015) 89(23):11935–44.10.1128/JVI.01792-1526378172
29. Yang Y, Tang H. Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumonia. Cell Mol Immunol (2016) 13(4):432–42.10.1038/cmi.2016.127041635
30. Peiris JS, Hui KP, Yen HL. Host response to influenza virus: protection versus immunopathology. Curr Opin Immunol (2010) 22(4):475–81.10.1016/j.coi.2010.06.00320594815
31. Kamal RP, Alymova IV, York IA. Evolution and virulence of influenza A virus protein PB1-F2. Int J Mol Sci (2018) 19(1):1–15.10.3390/ijms19010096
32. Mok BW, Liu H, Chen P, Liu S, Lau SY, Huang X, et al. The role of nuclear NS1 protein in highly pathogenic H5N1 influenza viruses. Microbes Infect (2017) 19(12):587–96.10.1016/j.micinf.2017.08.01128903072
33. Shanks GD, Brundage JF. Pathogenic responses among young adults during the 1918 influenza pandemic. Emerg Infect Dis (2012) 18(2):201–7.10.3201/eid1802.10204222306191
34. Loo YM, Gale M, Jr. Fatal immunity and the 1918 virus. Nature (2007) 445:267–8.10.1038/445267a
35. Kobasa D, Jones SM, Shinya K, Kash JC, Copps J, Ebihara H, et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature (2007) 445(7125):319–23.10.1038/nature0549517230189
36. Bertoletti A, Sette A, Chisari FV, Penna A, Levrero M, De Carli M, et al. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature (1994) 369:407–10.10.1038/369407a08196768
37. Berdal JE, Mollnes TE, Waehre T, Olstad OK, Halvorsen B, Ueland T, et al. Excessive innate immune response and mutant D222G/N in severe A (H1N1) pandemic influenza. J Infect (2011) 63(4):308–16.10.1016/j.jinf.2011.07.00421781987
38. Sridhar S, Begom S, Bermingham A, Hoschler K, Adamson W, Carman W, et al. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med (2013) 19(10):1305–12.10.1038/nm.335024056771
39. van de Sandt CE, Hillaire ML, Geelhoed-Mieras MM, Osterhaus AD, Fouchier RA, Rimmelzwaan GF. Human influenza A virus-specific CD8+ T-cell response is long-lived. J Infect Dis (2015) 212(1):81–5.10.1093/infdis/jiv01825583167
40. Reichman RC, Pons VG, Murphy BR, Caplan EA, Dolin R. Cell-mediated cytotoxicity following influenza infection and vaccination in humans. J Med Virol (1979) 4:1–14.10.1002/jmv.1890040102231094
41. Baharom FRG, Blomberg A, Smed-Sörensen A. Human lung mononuclear phagocytes in health and disease. Front Immunol (2017) 8:499.10.3389/fimmu.2017.00499
42. Short KR, Brooks AG, Reading PC, Londrigan SL. The fate of influenza A virus after infection of human macrophages and dendritic cells. J Gen Virol (2012) 93(Pt 11):2315–25.10.1099/vir.0.045021-022894921
43. Gill MA, Long K, Kwon T, Muniz L, Mejias A, Connolly J, et al. Differential recruitment of dendritic cells and monocytes to respiratory mucosal sites in children with influenza virus or respiratory syncytial virus infection. J Infect Dis (2008) 198(11):1667–76.10.1086/59301818847373
44. Gill MA, Palucka KA, Barton T, Ghaffar F, Jafri H, Banchereau J, et al. Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections. J Infect Dis (2005) 2005(191):1105–15.10.1086/42858915747246
45. Oshansky CM, Gartland AJ, Wong SS, Jeevan T, Wang D, Roddam PL, et al. Mucosal immune responses predict clinical outcomes during influenza infection independently of age and viral load. Am J Respir Crit Care Med (2014) 189(4):449–62.10.1164/rccm.201309-1616OC24308446
46. Cao W, Taylor AK, Biber RE, Davis WG, Kim JH, Reber AJ, et al. Rapid differentiation of monocytes into type I IFN-producing myeloid dendritic cells as an antiviral strategy against influenza virus infection. J Immunol (2012) 189(5):2257–65.10.4049/jimmunol.120016822855715
47. Diao H, Cui G, Wei Y, Chen J, Zuo J, Cao H, et al. Severe H7N9 infection is associated with decreased antigen-presenting capacity of CD14+ cells. PLoS One (2014) 9(3):e92823.10.1371/journal.pone.009282324664315
48. Lichtner M, Mastroianni CM, Rossi R, Russo G, Belvisi V, Marocco R, et al. Severe and persistent depletion of circulating plasmacytoid dendritic cells in patients with 2009 pandemic H1N1 infection. PLoS One (2011) 6(5):e19872.10.1371/journal.pone.001987221625541
49. Soloff AC, Weirback HK, Ross TM, Barratt-Boyes SM. Plasmacytoid dendritic cell depletion leads to an enhanced mononuclear phagocyte response in lungs of mice with lethal influenza virus infection. Comp Immunol Microbiol Infect Dis (2012) 35(4):309–17.10.1016/j.cimid.2012.01.01222421538
50. Guilliams M, Lambrecht BN, Hammad H. Division of labor between lung dendritic cells and macrophages in the defense against pulmonary infections. Mucosal Immunol (2013) 6(3):464–73.10.1038/mi.2013.1423549447
51. Baharom F, Thomas S, Rankin G, Lepzien R, Pourazar J, Behndig AF, et al. Dendritic cells and monocytes with distinct inflammatory responses reside in lung mucosa of healthy humans. J Immunol (2016) 196(11):4498–509.10.4049/jimmunol.160007127183618
52. Baharom F, Rankin G, Scholz S, Pourazar J, Ahlm C, Blomberg A, et al. Human lung dendritic cells: spatial distribution and phenotypic identification in endobronchial biopsies using immunohistochemistry and flow cytometry. J Vis Exp (2017) 119:e55222.10.3791/55222
53. Pulendran B, Tang H, Denning TL. Division of labor, plasticity, and crosstalk between dendritic cell subsets. Curr Opin Immunol (2008) 20(1):61–7.10.1016/j.coi.2007.10.00918082389
54. Gehr P, Bachofen M, Weibel E. The normal human lung – ultrastructure and morphometric estimation of diffusion capacity. Respir Physiol (1978) 32:121–40.10.1016/0034-5687(78)90104-4
55. Hamm H, Fabel H, Bartsch W. The surfactant system of the adult lung – physiology and clinical perspectives. Clin Investig (1992) 70:637–57.10.1007/BF00180279
56. Wonderlich ER, Swan ZD, Bissel SJ, Hartman AL, Carney JP, O’Malley KJ, et al. Widespread virus replication in alveoli drives acute respiratory distress syndrome in aerosolized H5N1 influenza infection of macaques. J Immunol (2017) 198(4):1616–26.10.4049/jimmunol.160177028062701
57. Granot T, Senda T, Carpenter DJ, Matsuoka N, Weiner J, Gordon CL, et al. Dendritic cells display subset and tissue-specific maturation dynamics over human life. Immunity (2017) 46(3):504–15.10.1016/j.immuni.2017.02.01928329707
58. Desch AN, Gibbings SL, Goyal R, Kolde R, Bednarek J, Bruno T, et al. Flow cytometric analysis of mononuclear phagocytes in nondiseased human lung and lung-draining lymph nodes. Am J Respir Crit Care Med (2016) 193(6):614–26.10.1164/rccm.201507-1376OC26551758
59. Patel VI, Booth JL, Duggan ES, Cate S, White VL, Hutchings D, et al. Transcriptional classification and functional characterization of human airway macrophage and dendritic cell subsets. J Immunol (2017) 198(3):1183–201.10.4049/jimmunol.160077728031342
60. Yu YR, Hotten DF, Malakhau Y, Volker E, Ghio AJ, Noble PW, et al. Flow cytometric analysis of myeloid cells in human blood, bronchoalveolar lavage, and lung tissues. Am J Respir Cell Mol Biol (2016) 54(1):13–24.10.1165/rcmb.2015-0146OC
61. Patel VI, Metcalf JP. Identification and characterization of human dendritic cell subsets in the steady state: a review of our current knowledge. J Investig Med (2016) 64(4):833–47.10.1136/jim-2016-00007226956785
62. Iwasaki A. Mucosal dendritic cells. Annu Rev Immunol (2007) 25:381–418.10.1146/annurev.immunol.25.022106.14163417378762
63. Fathi M, Johansson A, Lundborg M, Orre L, Skold CM, Camner P. Functional and morphological differences between human alveolar and interstitial macrophages. Exp Mol Pathol (2001) 70(2):77–82.10.1006/exmp.2000.234411263950
64. Thomas GD, Hamers AAJ, Nakao C, Marcovecchio P, Taylor AM, McSkimming C, et al. Human blood monocyte subsets: a new gating strategy defined using cell surface markers identified by mass cytometry. Arterioscler Thromb Vasc Biol (2017) 37(8):1548–58.10.1161/ATVBAHA.117.30914528596372
65. Ziegler-Heitbrock L. Blood monocytes and their subsets: established features and open questions. Front Immunol (2015) 6:423.10.3389/fimmu.2015.0042326347746
66. Abeles RD, McPhail MJ, Sowter D, Antoniades CG, Vergis N, Vijay GK, et al. CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14(hi)/CD16(neg) monocytes: expansion of CD14(hi)/CD16(pos) and contraction of CD14(lo)/CD16(pos) monocytes in acute liver failure. Cytometry A (2012) 81(10):823–34.10.1002/cyto.a.22104
67. Serbina NV, Pamer EG. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol (2006) 7(3):311–7.10.1038/ni130916462739
68. Patel AA, Zhang Y, Fullerton JN, Boelen L, Rongvaux A, Maini AA, et al. The fate and lifespan of human monocyte subsets in steady state and systemic inflammation. J Exp Med (2017) 214(7):1913–23.10.1084/jem.2017035528606987
69. Boyette LB, Macedo C, Hadi K, Elinoff BD, Walters JT, Ramaswami B, et al. Phenotype, function, and differentiation potential of human monocyte subsets. PLoS One (2017) 12(4):e0176460.10.1371/journal.pone.017646028445506
70. Alcantara-Hernandez M, Leylek R, Wagar LE, Engleman EG, Keler T, Marinkovich MP, et al. High-dimensional phenotypic mapping of human dendritic cells reveals interindividual variation and tissue specialization. Immunity (2017) 47(6):1037–50.e6.10.1016/j.immuni.2017.11.00129221729
71. See P, Dutertre CA, Chen J, Gunther P, McGovern N, Irac SE, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science (2017) 356(6342):1–13.10.1126/science.aag300928473638
72. Villani AC, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science (2017) 356(6335):1–12.10.1126/science.aah457328428369
73. Jongbloed SL, Kassianos AJ, McDonald KJ, Clark GJ, Ju X, Angel CE, et al. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med (2010) 207(6):1247–60.10.1084/jem.2009214020479116
74. De Monte AO, Olivieri CV, Vitale S, Bailleux S, Castillo L, Giordanengo V, et al. CD1c-related DCs that express CD207: Langerin, but are distinguishable from Langerhans cells, are consistently present in human tonsils. Front Immunol (2016) 7:197.10.3389/fimmu.2016.00197
75. Segura E, Durand M, Amigorena S. Similar antigen cross-presentation capacity and phagocytic functions in all freshly isolated human lymphoid organ-resident dendritic cells. J Exp Med (2013) 210(5):1035–47.10.1084/jem.2012110323569327
76. Segura E, Valladeau-Guilemond J, Donnadieu MH, Sastre-Garau X, Soumelis V, Amigorena S. Characterization of resident and migratory dendritic cells in human lymph nodes. J Exp Med (2012) 209(4):653–60.10.1084/jem.2011145722430490
77. Pinilla-Vera M, Xiong Z, Zhao Y, Zhao J, Donahoe MP, Barge S, et al. Full spectrum of LPS activation in alveolar macrophages of healthy volunteers by whole transcriptomic profiling. PLoS One (2016) 11(7):e0159329.10.1371/journal.pone.015932927434537
78. Liegeois M, Legrand C, Desmet CJ, Marichal T, Bureau F. The interstitial macrophage: a long-neglected piece in the puzzle of lung immunity. Cell Immunol (2018).10.1016/j.cellimm.2018.02.001
79. Duan M, Hibbs ML, Chen W. The contributions of lung macrophage and monocyte heterogeneity to influenza pathogenesis. Immunol Cell Biol (2017) 95(3):225–35.10.1038/icb.2016.9727670791
80. Shi C, Pamer EG. Monocyte recruitment during infection and inflammation. Nat Rev Immunol (2011) 11(11):762–74.10.1038/nri307021984070
81. Lee J, Tam H, Adler L, Ilstad-Minnihan A, Macaubas C, Mellins ED. The MHC class II antigen presentation pathway in human monocytes differs by subset and is regulated by cytokines. PLoS One (2017) 12(8):e0183594.10.1371/journal.pone.018359428832681
82. Kwissa M, Nakaya HI, Onlamoon N, Wrammert J, Villinger F, Perng GC, et al. Dengue virus infection induces expansion of a CD14(+)CD16(+) monocyte population that stimulates plasmablast differentiation. Cell Host Microbe (2014) 16(1):115–27.10.1016/j.chom.2014.06.00124981333
83. Standring S, Borley NR, Collins P, Crossman AR, Gatzoulis MA, Healy JC, et al. Gray’s Anatomy The Anatomical Basis of Clinical Practice. 40th ed. Standring S, editor. London, United Kingdom: Elsevier (2008).
84. Jochems SP, Piddock K, Rylance J, Adler H, Carniel BF, Collins A, et al. Novel analysis of immune cells from nasal microbiopsy demonstrates reliable, reproducible data for immune populations, and superior cytokine detection compared to nasal wash. PLoS One (2017) 12(1):e0169805.10.1371/journal.pone.016980528107457
85. Juliusson S, Bachert C, Klementsson H, Karlsson G, Pipkorn U. Macrophages on the nasal mucosal surface in provoked and naturally occurring allergic rhinitis. Acta Otolaryngol (2009) 111(5):946–53.10.3109/00016489109138435
86. Lee H, Ruane D, Law K, Ho Y, Garg A, Rahman A, et al. Phenotype and function of nasal dendritic cells. Mucosal Immunol (2015) 8(5):1083–98.10.1038/mi.2014.13525669151
87. Kopf M, Schneider C, Nobs SP. The development and function of lung-resident macrophages and dendritic cells. Nat Immunol (2015) 16(1):36–44.10.1038/ni.305225521683
88. Cole SL, Ho LP. Contribution of innate immune cells to pathogenesis of severe influenza virus infection. Clin Sci (Lond) (2017) 131(4):269–83.10.1042/CS2016048428108632
89. Sprenger H, Meyer RG, Kaufmann A, Bussfeld D, Rischkowsky E, Gemsa D. Selective induction of monocyte and not neutrophil-attracting chemokines after influenza A virus infection. J Exp Med (1996) 184:1191–6.10.1084/jem.184.3.1191
90. Cole SL, Dunning J, Kok WL, Benam KH, Benlahrech A, Repapi E, et al. M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenza. JCI Insight (2017) 2(7):e91868.10.1172/jci.insight.9186828405622
91. Hou W, Gibbs JS, Xiuju L, Brooke CB, Roy D, Modlin RL, et al. Viral infection triggers rapid differentiation of human blood monocytes into dendritic cells. Blood (2012) 119(13):3128–31.10.1182/blood-2011-09-379479
92. Lin KL, Suzuki Y, Nakano H, Ramsburg E, Gunn MD. CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality. J Immunol (2008) 180(4):2562–72.10.4049/jimmunol.180.4.256218250467
93. Lin SJ, Lee YC. Effect of influenza A infection on maturation and function of neonatal monocyte-derived dendritic cells. Viral Immunol (2014) 27(6):277–84.10.1089/vim.2014.000724834787
94. Dawson TC, Beck MA, Kuziel WA, Henderson F, Maeda N. Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am J Pathol (2000) 156(6):1951–9.10.1016/S0002-9440(10)65068-710854218
95. Herold S, Steinmueller M, von Wulffen W, Cakarova L, Pinto R, Pleschka S, et al. Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. J Exp Med (2008) 205(13):3065–77.10.1084/jem.2008020119064696
96. McGill J, Van Rooijen N, Legge KL. Protective influenza-specific CD8 T cell responses require interactions with dendritic cells in the lungs. J Exp Med (2008) 205(7):1635–46.10.1084/jem.2008031418591411
97. Helft J, Manicassamy B, Guermonprez P, Hashimoto D, Silvin A, Agudo J, et al. Cross-presenting CD103+ dendritic cells are protected from influenza virus infection. J Clin Invest (2012) 122(11):4037–47.10.1172/JCI6065923041628
98. Lawrence CW, Braciale TJ. Activation, differentiation, and migration of naive virus-specific CD8+ T cells during pulmonary influenza virus infection. J Immunol (2004) 173(2):1209–18.10.4049/jimmunol.173.2.120915240712
99. Lawrence CW, Ream RM, Braciale TJ. Frequency, specificity, and sites of expansion of CD8+ T cells during primary pulmonary influenza virus infection. J Immunol (2005) 174(9):5332–40.10.4049/jimmunol.174.9.533215843530
100. Yu CI, Becker C, Wang Y, Marches F, Helft J, Leboeuf M, et al. Human CD1c+ dendritic cells drive the differentiation of CD103+ CD8+ mucosal effector T cells via the cytokine TGF-beta. Immunity (2013) 38(4):818–30.10.1016/j.immuni.2013.03.004
101. Hemont C, Neel A, Heslan M, Braudeau C, Josien R. Human blood mDC subsets exhibit distinct TLR repertoire and responsiveness. J Leukoc Biol (2013) 93(4):599–609.10.1189/jlb.091245223341538
102. Kool M, Geurtsvankessel C, Muskens F, Madeira FB, van Nimwegen M, Kuipers H, et al. Facilitated antigen uptake and timed exposure to TLR ligands dictate the antigen-presenting potential of plasmacytoid DCs. J Leukoc Biol (2011) 90(6):1177–90.10.1189/jlb.061034221934071
103. Matsui T, Connolly JE, Michnevitz M, Chaussabel D, Yu CI, Glaser C, et al. CD2 distinguishes two subsets of human plasmacytoid dendritic cells with distinct phenotype and functions. J Immunol (2009) 182(11):6815–23.10.4049/jimmunol.080200819454677
104. Haller K. Human MxA protein – an interferon-induced dynamin-like GTPase with broad antiviral activity. J Interferon Cytokine Res (2011) 31(1):79–87.10.1089/jir.2010.0076
105. Sakabe S, Iwatsuki-Horimoto K, Takano R, Nidom CA, Le M, Nagamura-Inoue T, et al. Cytokine production by primary human macrophages infected with highly pathogenic H5N1 or pandemic H1N1 2009 influenza viruses. J Gen Virol (2011) 92(Pt 6):1428–34.10.1099/vir.0.030346-021367984
106. Short KR, Kasper J, van der Aa S, Andeweg AC, Zaaraoui-Boutahar F, Goeijenbier M, et al. Influenza virus damages the alveolar barrier by disrupting epithelial cell tight junctions. Eur Respir J (2016) 47(3):954–66.10.1183/13993003.01282-201526743480
107. Schlitzer A, McGovern N, Teo P, Zelante T, Atarashi K, Low D, et al. IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity (2013) 38(5):970–83.10.1016/j.immuni.2013.04.01123706669
108. Faith A, McDonald J, Peek E, Richards D, Caulfield J, Chevretton E, et al. Functional plasticity of human respiratory tract dendritic cells: GM-CSF enhances T(H)2 development. J Allergy Clin Immunol (2005) 116(5):1136–43.10.1016/j.jaci.2005.08.00216275388
109. Bogiatzi SI, Guillot-Delost M, Cappuccio A, Bichet JC, Chouchane-Mlik O, Donnadieu MH, et al. Multiple-checkpoint inhibition of thymic stromal lymphopoietin-induced TH2 response by TH17-related cytokines. J Allergy Clin Immunol (2012) 130(1):233–40.e5.10.1016/j.jaci.2012.04.038
110. Di Pucchio T, Chatterjee B, Smed-Sorensen A, Clayton S, Palazzo A, Montes M, et al. Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I. Nat Immunol (2008) 9(5):551–7.10.1038/ni.160218376401
111. Fonteneau JF, Gilliet M, Larsson M, Dasilva I, Munz C, Liu YJ, et al. Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity. Blood (2003) 101(9):3520–6.10.1182/blood-2002-10-306312511409
112. Haller O, Gao S, von der Malsburg A, Daumke O, Kochs G. Dynamin-like MxA GTPase: structural insights into oligomerization and implications for antiviral activity. J Biol Chem (2010) 285(37):28419–24.10.1074/jbc.R110.145839
113. Wang J, Nikrad MP, Travanty EA, Zhou B, Phang T, Gao B, et al. Innate immune response of human alveolar macrophages during influenza A infection. PLoS One (2012) 7(3):e29879.10.1371/journal.pone.002987922396727
114. Friesenhagen J, Boergeling Y, Hrincius E, Ludwig S, Roth J, Viemann D. Highly pathogenic avian influenza viruses inhibit effective immune responses of human blood-derived macrophages. J Leukoc Biol (2012) 92(1):11–20.10.1189/jlb.091147922442495
115. Friesenhagen J, Viemann D, Börgeling Y, Schmolke M, Spiekermann C, Kirschnek S, et al. Highly pathogenic influenza viruses inhibit inflammatory response in monocytes via activation of Rar-related orphan receptor RORa. J Innate Immun (2013) 5:505–18.10.1159/000346706
116. Kuiken T, van den Brand J, van Riel D, Pantin-Jackwood M, Swayne DE. Comparative pathology of select agent influenza a virus infections. Vet Pathol (2010) 47(5):893–914.10.1177/030098581037865120682805
117. Guarner J, Falcon-Escobedo R. Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses. Arch Med Res (2009) 40(8):655–61.10.1016/j.arcmed.2009.10.001
118. Nakajima N, Sato Y, Katano H, Hasegawa H, Kumasaka T, Hata S, et al. Histopathological and immunohistochemical findings of 20 autopsy cases with 2009 H1N1 virus infection. Mod Pathol (2012) 25(1):1–13.10.1038/modpathol.2011.12521874012
119. Hoeve MA, Nash AA, Jackson D, Randall RE, Dransfield I. Influenza virus A infection of human monocyte and macrophage subpopulations reveals increased susceptibility associated with cell differentiation. PLoS One (2012) 7(1):e29443.10.1371/journal.pone.002944322238612
120. Yu WC, Chan RW, Wang J, Travanty EA, Nicholls JM, Peiris JS, et al. Viral replication and innate host responses in primary human alveolar epithelial cells and alveolar macrophages infected with influenza H5N1 and H1N1 viruses. J Virol (2011) 85(14):6844–55.10.1128/JVI.02200-1021543489
121. Smed-Sorensen A, Chalouni C, Chatterjee B, Cohn L, Blattmann P, Nakamura N, et al. Influenza A virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cells. PLoS Pathog (2012) 8(3):e1002572.10.1371/journal.ppat.100257222412374
122. Baharom F, Thomas OS, Lepzien R, Mellman I, Chalouni C, Smed-Sorensen A. Visualization of early influenza A virus trafficking in human dendritic cells using STED microscopy. PLoS One (2017) 12(6):e0177920.10.1371/journal.pone.017792028591131
123. Aldridge JRJ, Moseley CE, Boltz DA, Negovetich NJ, Reynolds C, Franks J, et al. TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc Natl Acad Sci U S A (2009) 106(13):5306–11.10.1073/pnas.090065510619279209
124. Thomas JM, Pos Z, Reinboth J, Wang RY, Wang E, Frank GM, et al. Differential responses of plasmacytoid dendritic cells to influenza virus and distinct viral pathogens. J Virol (2014) 88(18):10758–66.10.1128/JVI.01501-1425008918
125. Vanders RL, Gibson PG, Murphy VE, Wark PA. Plasmacytoid dendritic cells and CD8 T cells from pregnant women show altered phenotype and function following H1N1/09 infection. J Infect Dis (2013) 208(7):1062–70.10.1093/infdis/jit29623861550
126. Wu W, Booth JL, Duggan ES, Wu S, Patel KB, Coggeshall KM, et al. Innate immune response to H3N2 and H1N1 influenza virus infection in a human lung organ culture model. Virology (2010) 396(2):178–88.10.1016/j.virol.2009.10.01619913271
127. Silvin A, Yu CI, Lahaye X, Imperatore F, Brault J-B, Cardinaud S, et al. Constitutive resistance to viral infection in human CD141+ dendritic cells. Sci Immunol (2017) 2(13):1–12.10.1126/sciimmunol.aai807128783704
128. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, et al. Immunobiology of dendritic cells. Annu Rev Immunol (2000) 18:767–811.10.1146/annurev.immunol.18.1.767
129. Merad M, Sathe P, Helft J, Miller J, Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol (2013) 31:563–604.10.1146/annurev-immunol-020711-07495023516985
130. Pulendran B. The varieties of immunological experience: of pathogens, stress, and dendritic cells. Annu Rev Immunol (2015) 33:563–606.10.1146/annurev-immunol-020711-07504925665078
131. Randolph GJ, Angeli V, Swartz MA. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol (2005) 5(8):617–28.10.1038/nri167016056255
132. Waithman J, Mintern JD. Dendritic cells and influenza A virus infection. Virulence (2012) 3(7):603–8.10.4161/viru.2186423076333
133. Clark GJ, Kupresanin F, Fromm PD, Ju X, Muusers L, Silveira PA, et al. New insights into the phenotype of human dendritic cell populations. Clin Transl Immunol (2016) 5(1):e61.10.1038/cti.2015.4026900474
134. Perrone LA, Plowden JK, Garcia-Sastre A, Katz JM, Tumpey TM. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog (2008) 4(8):e1000115.10.1371/journal.ppat.100011518670648
135. Idoyaga J, Fiorese C, Zbytnuik L, Lubkin A, Miller J, Malissen B, et al. Specialized role of migratory dendritic cells in peripheral tolerance induction. J Clin Invest (2013) 123(2):844–54.10.1172/JCI65260
136. GeurtsvanKessel CH, Bergen IM, Muskens F, Boon L, Hoogsteden HC, Osterhaus AD, et al. Both conventional and interferon killer dendritic cells have antigen-presenting capacity during influenza virus infection. PLoS One (2009) 4(9):e7187.10.1371/journal.pone.000718719784375
137. Cella M. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med (1999) 5(8):919–23.10.1038/11360
138. Pulendran B, Maddur MS. Innate immune sensing and response to influenza. Curr Top Microbiol Immunol (2015) 386:23–71.10.1007/82_2014_40525078919
139. Chen X, Liu S, Goraya MU, Maarouf M, Huang S, Chen JL. Host immune response to influenza A virus infection. Front Immunol (2018) 9(320):1–13.10.3389/fimmu.2018.0032029556226
140. Ascough S, Paterson S, Chiu C. Induction and subversion of human protective immunity – contrasting influenza and respiratory syncytial virus. Front Immunol (2018) 9(323):1–23.10.3389/fimmu.2018.00323
141. Miyauchi K. Helper T cell responses to respiratory viruses in the lung: development, virus suppression, and pathogenesis. Viral Immunol (2017) 30(6):421–30.10.1089/vim.2017.0018
142. Gan H, Hao Q, Idell S, Tang H. Transcription factor Runx3 is induced by influenza A virus and double-strand RNA and mediates airway epithelial cell apoptosis. Sci Rep (2015) 5:17916.10.1038/srep1791626643317
143. Kim S, Kim MJ, Park DY, Chung HJ, Kim CH, Yoon JH, et al. Mitochondrial reactive oxygen species modulate innate immune response to influenza A virus in human nasal epithelium. Antiviral Res (2015) 119:78–83.10.1016/j.antiviral.2015.04.01125930096
144. McAuley JL, Corcilius L, Tan HX, Payne RJ, McGuckin MA, Brown LE. The cell surface mucin MUC1 limits the severity of influenza A virus infection. Mucosal Immunol (2017) 10(6):1581–93.10.1038/mi.2017.1628327617
145. Shin N, Pyo CW, Jung KI, Choi SY. Influenza A virus PB1-F2 is involved in regulation of cellular redox state in alveolar epithelial cells. Biochem Biophys Res Commun (2015) 459(4):699–705.10.1016/j.bbrc.2015.03.01025769947
146. Oughton M, Dascal A, Laporta D, Charest H, Afilalo M, Miller M. Evidence of viremia in 2 cases of severe pandemic influenza A H1N1/09. Diagn Microbiol Infect Dis (2011) 70(2):213–7.10.1016/j.diagmicrobio.2010.12.01321397429
147. Sobata R, Matsumoto C, Igarashi M, Uchida S, Momose S, Hino S, et al. No viremia of pandemic (H1N1) 2009 was demonstrated in blood donors who had donated blood during the probable incubation period. Transfusion (2011) 51(9):1949–56.10.1111/j.1537-2995.2011.03109.x21414008
148. Jamieson AM, Yu S, Annicelli CH, Medzhitov R. Influenza virus-induced glucocorticoids compromise innate host defense against a secondary bacterial infection. Cell Host Microbe (2010) 7(2):103–14.10.1016/j.chom.2010.01.010
149. Nita-Lazar M, Banerjee A, Feng C, Amin MN, Frieman MB, Chen WH, et al. Desialylation of airway epithelial cells during influenza virus infection enhances pneumococcal adhesion via galectin binding. Mol Immunol (2015) 65(1):1–16.10.1016/j.molimm.2014.12.01025597246
150. Baharom F, Thomas S, Bieder A, Hellmer M, Volz J, Sandgren KJ, et al. Protection of human myeloid dendritic cell subsets against influenza A virus infection is differentially regulated upon TLR stimulation. J Immunol (2015) 194(9):4422–30.10.4049/jimmunol.140267125801434
151. Levy O, Zarember KA, Roy RM, Cywes C, Godowski PJ, Wessels MR. Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-α induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J Immunol (2004) 173(7):4627–34.10.4049/jimmunol.173.7.4627
152. Marr N, Wang TI, Kam SH, Hu YS, Sharma AA, Lam A, et al. Attenuation of respiratory syncytial virus-induced and RIG-I-dependent type I IFN responses in human neonates and very young children. J Immunol (2014) 192(3):948–57.10.4049/jimmunol.130200724391215
153. Molony RD, Nguyen JT, Kong Y, Montgomery RR, Shaw AC, Iwasaki A. Aging impairs both primary and secondary RIG-I signaling for interferon induction in human monocytes. Sci Signal (2017) 10(509):1–11.10.1126/scisignalaan2392
154. Chong SZ, Wong KL, Lin G, Yang CM, Wong SC, Angeli V, et al. Human CD8(+) T cells drive Th1 responses through the differentiation of TNF/iNOS-producing dendritic cells. Eur J Immunol (2011) 41(6):1639–51.10.1002/eji.201041022